NCT00180453View on ClinicalTrials.gov

SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

April 30, 2005

Study Completion Date

June 30, 2009

Conditions
Coronary Artery DiseaseEverolimusVascular DiseaseMyocardial IschemiaCoronary Artery Stenosis
Interventions
DEVICE

Coronary artery drug eluting stent placement

Coronary artery drug eluting stent placement

DEVICE

Coronary artery stent placement

Coronary artery stent placement

Trial Locations (7)

32545

Herzzentrum Bad Oeynhausen, Bad Oeynhausen

61231

Kerckhoff-Klinik, Bad Nauheim

79189

Herzzentrum Bad Krozingen, Bad Krozingen

Unknown

Skejby Sygehus, Aarhus

Herzzentrum Siegburg GmbH, Siegburg

Erasmus Medical Center, Rotterdam

1105 AZ

Academisch Medisch Centrum, Amsterdam

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY